158 related articles for article (PubMed ID: 38530158)
1. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis.
Balasubramanian A; Hsu AY; Ghimire L; Tahir M; Devant P; Fontana P; Du G; Liu X; Fabin D; Kambara H; Xie X; Liu F; Hasegawa T; Xu R; Yu H; Chen M; Kolakowski S; Trauger S; Larsen MR; Wei W; Wu H; Kagan JC; Lieberman J; Luo HR
Sci Immunol; 2024 Apr; 9(94):eadn1452. PubMed ID: 38530158
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis.
Balasubramanian A; Ghimire L; Hsu AY; Kambara H; Liu X; Hasegawa T; Xu R; Tahir M; Yu H; Lieberman J; Luo HR
bioRxiv; 2023 Feb; ():. PubMed ID: 36865189
[TBL] [Abstract][Full Text] [Related]
3. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D.
Du G; Healy LB; David L; Walker C; El-Baba TJ; Lutomski CA; Goh B; Gu B; Pi X; Devant P; Fontana P; Dong Y; Ma X; Miao R; Balasubramanian A; Puthenveetil R; Banerjee A; Luo HR; Kagan JC; Oh SF; Robinson CV; Lieberman J; Wu H
Nature; 2024 Jun; 630(8016):437-446. PubMed ID: 38599239
[TBL] [Abstract][Full Text] [Related]
4. A palmitoylation-depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis.
Zhang N; Zhang J; Yang Y; Shan H; Hou S; Fang H; Ma M; Chen Z; Tan L; Xu D
Nat Cell Biol; 2024 May; 26(5):757-769. PubMed ID: 38538834
[TBL] [Abstract][Full Text] [Related]
5. ROS-dependent palmitoylation is an obligate licensing modification for GSDMD pore formation.
Du G; Healy LB; David L; Walker C; Fontana P; Dong Y; Devant P; Puthenveetil R; Ficarro SB; Banerjee A; Kagan JC; Lieberman J; Wu H
bioRxiv; 2023 Mar; ():. PubMed ID: 36945424
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction.
Zhuang Z; Gu J; Li BO; Yang L
Transl Res; 2024 Feb; 264():66-75. PubMed ID: 37769810
[TBL] [Abstract][Full Text] [Related]
7. NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation.
Jiang X; Zhang X; Cai X; Li N; Zheng H; Tang M; Zhu J; Su K; Zhang R; Ye N; Peng J; Zhao M; Wu W; Yang J; Ye H
Sci Adv; 2024 Feb; 10(6):eadi9284. PubMed ID: 38324683
[TBL] [Abstract][Full Text] [Related]
8. New insights into Gasdermin D pore formation.
Kappelhoff S; Margheritis EG; Cosentino K
Biochem Soc Trans; 2024 Apr; 52(2):681-692. PubMed ID: 38497302
[TBL] [Abstract][Full Text] [Related]
9. Gasdermin D palmitoylation: to cleave or not to cleave?
Stine L; Humphries F
Trends Immunol; 2024 Jun; 45(6):403-405. PubMed ID: 38760304
[TBL] [Abstract][Full Text] [Related]
10. When pyro(ptosis) meets palm(itoylation).
Jiang L; Wang Z; Xu T; Zhang L
Cytokine Growth Factor Rev; 2024 Jun; 77():30-38. PubMed ID: 38472042
[TBL] [Abstract][Full Text] [Related]
11. Chaiqin chengqi decoction alleviates acute pancreatitis by targeting gasdermin D-mediated pyroptosis.
Cao F; Xiang J; Wang Y; Chen X; Lu X; Xu X; Chen L; Fan Y; Yuan C; Dong X; Zhu Q; Han C; Lu G; Xia Q; Chen W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116920. PubMed ID: 37480969
[TBL] [Abstract][Full Text] [Related]
12. Effects of amyloid β (Aβ)42 and Gasdermin D on the progression of Alzheimer's disease
Hong W; Hu C; Wang C; Zhu B; Tian M; Qin H
Aging (Albany NY); 2023 Nov; 15(21):12209-12224. PubMed ID: 37921870
[TBL] [Abstract][Full Text] [Related]
13. Pyroptosis inhibiting nanobodies block Gasdermin D pore formation.
Kopp A; Hagelueken G; Jamitzky I; Moecking J; Schiffelers LDJ; Schmidt FI; Geyer M
Nat Commun; 2023 Dec; 14(1):7923. PubMed ID: 38040708
[TBL] [Abstract][Full Text] [Related]
14. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis.
Miao R; Jiang C; Chang WY; Zhang H; An J; Ho F; Chen P; Zhang H; Junqueira C; Amgalan D; Liang FG; Zhang J; Evavold CL; Hafner-Bratkovič I; Zhang Z; Fontana P; Xia S; Waldeck-Weiermair M; Pan Y; Michel T; Bar-Peled L; Wu H; Kagan JC; Kitsis RN; Zhang P; Liu X; Lieberman J
Immunity; 2023 Nov; 56(11):2523-2541.e8. PubMed ID: 37924812
[TBL] [Abstract][Full Text] [Related]
15. Gasdermin D in pyroptosis.
Burdette BE; Esparza AN; Zhu H; Wang S
Acta Pharm Sin B; 2021 Sep; 11(9):2768-2782. PubMed ID: 34589396
[TBL] [Abstract][Full Text] [Related]
16. Determination of Gasdermin Pores.
Wang K; Ding J; Shao F
Methods Mol Biol; 2023; 2696():149-167. PubMed ID: 37578722
[TBL] [Abstract][Full Text] [Related]
17. Gasdermins in Innate Host Defense Against
Wang S; Moreau F; Chadee K
Front Immunol; 2022; 13():900553. PubMed ID: 35795683
[TBL] [Abstract][Full Text] [Related]
18. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors.
Dai Z; Liu WC; Chen XY; Wang X; Li JL; Zhang X
Front Immunol; 2023; 14():1178662. PubMed ID: 37275856
[TBL] [Abstract][Full Text] [Related]
19. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway.
Evavold CL; Hafner-Bratkovič I; Devant P; D'Andrea JM; Ngwa EM; Boršić E; Doench JG; LaFleur MW; Sharpe AH; Thiagarajah JR; Kagan JC
Cell; 2021 Aug; 184(17):4495-4511.e19. PubMed ID: 34289345
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion.
He WT; Wan H; Hu L; Chen P; Wang X; Huang Z; Yang ZH; Zhong CQ; Han J
Cell Res; 2015 Dec; 25(12):1285-98. PubMed ID: 26611636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
